Ivosidenib for Patients with Clonal Cytopenia of Undetermined Significance and Mutations in IDH1

被引：1
|
作者：
Petrone, Giulia [1 ]
Stein, Eytan M. [2 ]
Bolton, Kelly L. [3 ]
机构：
[1] Washington Univ St Louis, Dept Med, Div Hematol & Oncol, St Louis, MO USA
[2] Mem Sloan Kettering Canc Ctr, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
[3] Washington Univ St Louis, Sch Med, Dept Med, Div Oncol,Sect Stem Cell Biol, St Louis, MO 63110 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184977
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Ivosidenib: Targeted therapy option for IDH1 mutations
    Freyer, Martina
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (12) : 630 - 632
  • [2] Characterization of TP53 mutations in clonal cytopenia of undetermined significance
    Wang, Wei
    Routbort, Mark J.
    Ok, Chi Young
    Patel, Keyur P.
    Sun, Yi
    Kanagal-Shamanna, Rashmi
    Medeiros, L. Jeffrey
    Wang, Sa A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E175 - E177
  • [3] Ivosidenib in the treatment of patients with IDH1 mutated cholangiocarcinoma
    Chmielewska, Agnieszka
    Kubiatowski, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 286 - 290
  • [4] THE USE OF IVOSIDENIB IN PATIENTS WITH ENHANCING IDH1 MUTANT GLIOMAS
    Minor, Maria
    Ziv, Michal Nisnboym
    Patel, Mallika
    Johnson, Margaret
    Batich, Kristen
    Low, Justin
    Shoaf, Madison
    Khasraw, Mustafa
    Desjardins, Annick
    Friedman, Henry
    Ashley, David
    Peters, Katherine
    NEURO-ONCOLOGY, 2024, 26
  • [5] A Clinical Overview of Clonal Cytopenia of Undetermined Significance in the Presence of ZRSR2 Mutations
    Yacout, Mahmoud
    Katamesh, Bahga
    Jabban, Yazan
    He, Rong
    Greipp, Patricia
    Jevremovic, Dragan
    Foran, James M.
    Yi, Cecilia Y. Arana
    Saliba, Antoine N.
    Mangaonkar, Abhishek A.
    Shah, Mithun, V
    Patnaik, Mrinal M.
    Alkhateeb, Hassan B.
    Al-Kali, Aref
    BLOOD, 2024, 144 : 2667 - 2668
  • [6] Flow Cytometry Findings in Clonal Cytopenia and Undetermined Significance
    Meyerson, Howard
    Alayed, Khaled
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 876 - 877
  • [7] Clinical and pathologic challenges of clonal cytopenia of undetermined significance
    Weinberg, Olga K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 : 82 - 85
  • [8] Flow Cytometry Findings in Clonal Cytopenia and Undetermined Significance
    Meyerson, Howard
    Alayed, Khaled
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 876 - 877
  • [9] Flow Cytometric Findings in Clonal Cytopenia of Undetermined Significance
    Nirmalanantham, Priyatharsini
    Sakhi, Ramen
    Beck, Rose
    Oduro, Kwadwo
    Gadde, Ramya
    Ryder, Chris
    Yoest, Jennifer
    Sadri, Navid
    Meyerson, Howard J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 157 (02) : 219 - 230
  • [10] Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma
    James M. Cleary
    Betty Rouaisnel
    Antoine Daina
    Srivatsan Raghavan
    Lauren A. Roller
    Brandon M. Huffman
    Harshabad Singh
    Patrick Y. Wen
    Nabeel Bardeesy
    Vincent Zoete
    Brian M. Wolpin
    Julie-Aurore Losman
    npj Precision Oncology, 6
12345